Sign in
Taking people in United StatesNo phase

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Key facts

Who runs it
The Eye institute of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
9 Jan 2025
Planned end
22 Feb 2025
Type of study
Observational
Record updated
30 January 2025

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • 21 years or older (Adult age)
  • Assessed to have Cataract Grade 1 and above per LOCS III or Wisconsin Grading scale in at least one eye
  • Able to comprehend and sign the informed consent form
  • Potential postoperative best corrected distance visual acuity (BCDVA) of 0.3 logMAR or better and targeted post-op refraction to be emmetropia, based on the investigator expert medical opinion

Who cannot take part

  • No active ocular infection or inflammation
  • Contraindicated for pupil dilation (e.g., narrow angles, allergies) per medical judgement of the investigator
  • Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study
  • Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Cataract

This trial is currently available in United States.

  • The Eye Institute of UtahSalt Lake City, United StatesContact: Lexi GuildTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.

The group in the trial

  • Observational

    No interventions will be administered.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06801678, who can take part
Record updated
30 January 2025